164 related articles for article (PubMed ID: 27756156)
1. Inhaled budesonide for the prevention of bronchopulmonary dysplasia.
Bassler D
J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2372-2374. PubMed ID: 27756156
[TBL] [Abstract][Full Text] [Related]
2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
3. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
[TBL] [Abstract][Full Text] [Related]
4. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
[TBL] [Abstract][Full Text] [Related]
5. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis.
Zhang M; Zhang W; Liao H
Respir Med Res; 2024 Jun; 85():101096. PubMed ID: 38744231
[TBL] [Abstract][Full Text] [Related]
7. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
Pantalitschka T; Poets CF
Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
[TBL] [Abstract][Full Text] [Related]
8. Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.
Zhang ZQ; Zhong Y; Huang XM; Du LZ
BMC Pulm Med; 2017 Dec; 17(1):207. PubMed ID: 29246209
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.
Bassler D; Shinwell ES; Hallman M; Jarreau PH; Plavka R; Carnielli V; Meisner C; Engel C; Koch A; Kreutzer K; van den Anker JN; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2018 Jan; 378(2):148-157. PubMed ID: 29320647
[TBL] [Abstract][Full Text] [Related]
10. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
[TBL] [Abstract][Full Text] [Related]
11. [Glucocorticoide therapy in premature infants: French practices in 2006].
Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
[TBL] [Abstract][Full Text] [Related]
12. Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal.
Rüegger CM; Bassler D
Semin Fetal Neonatal Med; 2019 Jun; 24(3):207-212. PubMed ID: 30992184
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Glucocorticoids and Pneumonia in Preterm Infants: Post Hoc Results from the NEuroSIS Trial.
Koch A; Kreutzer K; von Oldershausen G; Poets CF; Bassler D;
Neonatology; 2017; 112(2):110-113. PubMed ID: 28456800
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
Szabó H; Baraldi E; Colin AA
Pediatr Pulmonol; 2022 Apr; 57(4):787-795. PubMed ID: 34964564
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.
Ramaswamy VV; Bandyopadhyay T; Nanda D; Bandiya P; Ahmed J; Garg A; Roehr CC; Nangia S
JAMA Pediatr; 2021 Jun; 175(6):e206826. PubMed ID: 33720274
[TBL] [Abstract][Full Text] [Related]
16. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
PLoS One; 2014; 9(9):e106838. PubMed ID: 25192252
[TBL] [Abstract][Full Text] [Related]
17. Use of inhaled corticosteroids for the prevention and/or treatment of bronchopulmonary dysplasia in preterm infants: a systematic review protocol.
Shinwell ES; Portnov I; Meerpohl J; Karen T; Bassler D
Syst Rev; 2015 Sep; 4():127. PubMed ID: 26420776
[TBL] [Abstract][Full Text] [Related]
18. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.
Bassler D; van den Anker J
Pediatr Clin North Am; 2017 Dec; 64(6):1355-1367. PubMed ID: 29173790
[TBL] [Abstract][Full Text] [Related]
19. Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
Filippone M; Nardo D; Bonadies L; Salvadori S; Baraldi E
Am J Perinatol; 2019 Jul; 36(S 02):S58-S62. PubMed ID: 31238361
[TBL] [Abstract][Full Text] [Related]
20. Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis.
Shinwell ES; Portnov I; Meerpohl JJ; Karen T; Bassler D
Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
